Sai Life Sciences IPO

7.54x

subscribed

Sai Life Sciences IPO

Pharmaceuticals & Drugs
listed
₹14,094Min. investment
  1. Pre-apply
    10 Dec
  2. Bid start
    11 Dec
  3. Bid end
    13 Dec
  4. Allotment
    16 Dec
  5. Release of funds
    17 Dec
  6. Demat transfer
    17 Dec
  7. Listing
    18 Dec

About Sai Life Sciences Limited

SectorPharmaceuticals & Drugs
Price range₹522 – ₹549
IPO type
Regular
Lot size27 shares
Issue size₹3,042Cr
Red Herring Prospectus
Read

Market Cap

₹11,418.6CrHigher than sector avg

Revenue

Apr 2023 - Mar 2024
₹1,465.1CrHigher than sector avg

Growth rate

3Y CAGR
19.00%

Checklist

Quality analysis

Revenue growth
Company valuation
Earnings expansion

Risk analysis

Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Compare

Companies in this sector

Sun Pharmaceutical Industries LtdSun Pharmaceutical Industries Ltd
Divi's Laboratories LtdDivi's Laboratories Ltd
Cipla LtdCipla Ltd

Revenue

Higher revenue means strong sales and good market demand
This IPO
₹1,465.1Cr
This sector
₹1,248.4Cr
Compare with companies

PAT

Higher PAT means strong profitability and efficient cost management
This IPO
₹82.8Cr
This sector
₹151.06Cr
Compare with companies

Market cap

Higher market cap means strong confidence but may suggest overvaluation
This IPO
₹11,418.6Cr
This sector
₹10,175.18Cr
Compare with companies

P/E ratio

Lower ratio usually means stock is undervalued
This IPO
120.10
This sector
38.61
Compare with companies

D/E ratio

Lower ratio usually means fewer liabilities
This IPO
0.75
This sector
1.54
Compare with companies
Objectives
Debt Repayment
The company will use the net proceeds worth ₹720 crore to repay/prepay, in full
General Corporate Purpose
Company will use part of the IPO proceeds for general cooprate purposes.
Offer For Sale
Part of the IPO proceeds worth ₹2,092.6 crore will go to selling shareholders.

About Sai Life Sciences IPO

Sai Life Sciences Limited is a contract research, development, and manufacturing organisation (CRDMO) founded in 1999. The company provides end-to-end services across the drug discovery, development, and manufacturing value chain to global pharmaceutical and biotechnology companies. The company’s CRO and CDMO services span early drug discovery, clinical trial support, and commercial drug manufacturing, with a portfolio of 170+ innovator pharmaceutical products. In FY24, revenue from CRO business made up 33.85% of total revenue, while the rest was contributed by the company’s CDMO business. Meanwhile, revenue from its top ten customers made up 46.2% of overall revenue.

Latest News on IPO

news logo
Subscriptions for Sai Life Sciences’ initial public offering (IPO) will go live on Wednesday, December 11, and end on Friday, December 13. The business intends to raise around Rs 3,042 crore through this public offering. Before you subscribe to the issue, read these ten things about the Sai Life Sciences IPO. Sai Life Sciences offers multinational pharmaceutical innovator businesses.
news logo
📌Sai Life Sciences has fixed price band of the upcoming IPO at Rs 522 to ₹549 per equity share. 📌Sai Life Sciences IPO opens for subscription on December 11 and closes on December 13, 2024. 📌Sai Life Sciences is a ₹950 crore fresh issue and 3.81 crore shares under OFS, with a total size of ₹2,940-3,043 crore. 📌The likely date for share allotment is Monday, December 16, 2024.
news logo
Sai Life Sciences, backed by TPG Capital, is set to launch its ₹3,043 crore IPO on December 11, 2024, with a price band of ₹522-549 per share. The offering includes a fresh issue of ₹950 crore and an Offer For Sale (OFS) of 3.81 crore shares by promoters and investors, including TPG Asia VII and HBM Private Equity India.

3 min read

Frequently asked questions

How to invest in the IPO?

Investors can apply for the IPO through their Demat account via the stock exchange or through their broker.

What is the issue size of Sai Life Sciences IPO ?

The issue size of the Sai Life Sciences IPO is 3042 Cr.

What is 'pre-apply' for Sai Life Sciences IPO ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Sai Life Sciences IPO shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.